Fuad El-Hibri, Chairman at Emergent BioSolutions Inc. (EBS), sold 20,000 shares at $62.90 ($1.3M) on 2020-02-12, disclosed to the SEC on 2020-02-13.
Open-market sale of $1.3M EBS by Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.90 | 6,280 | $395K | 31.4% |
| 2 | $62.90 | 13,720 | $863K | 68.6% |
| Total | $62.90 avg | 20,000 | $1.3M | 100% |
| Filing → |
| EBS | SELL | 2020-09-25 | $3.8M | — | Filing → |
| EBS | SELL | 2020-09-18 | $6.1M | — | Filing → |
| EBS | SELL | 2020-09-11 | $4.1M | — | Filing → |